Clinical Trial Update: A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating golimumab (SIMPONI) in children, adolescents and young adults with pre-symptomatic Type 1 diabetes has completed. The study ai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Pre-Symptomatic Type 1 Diabetes | Phase 1 | Status: COMPLETED